BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bai ZZ, Li HY, Li CH, Sheng CL, Zhao XN. M1 Macrophage-Derived Exosomal MicroRNA-326 Suppresses Hepatocellular Carcinoma Cell Progression Via Mediating NF-κB Signaling Pathway. Nanoscale Res Lett 2020;15:221. [PMID: 33263825 DOI: 10.1186/s11671-020-03432-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 18] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Cheng K, Cai N, Zhu J, Yang X, Liang H, Zhang W. Tumor-associated macrophages in liver cancer: From mechanisms to therapy. Cancer Commun (Lond) 2022. [PMID: 36069342 DOI: 10.1002/cac2.12345] [Reference Citation Analysis]
2 Youssef SS, Elfiky A, Nabeel MM, Shousha HI, Elbaz T, Omran D, Marie MS, Elzahry MA, Abul-Fotouh A, Hashem A, Guda MF, Abdelaziz AO. Assessment of circulating levels of microRNA-326, microRNA-424, and microRNA-511 as biomarkers for hepatocellular carcinoma in Egyptians. World J Hepatol 2022; 14(8): 1562-1575 [DOI: 10.4254/wjh.v14.i8.1562] [Reference Citation Analysis]
3 Tian BW, Han CL, Dong ZR, Tan SY, Wang DX, Li T. Role of Exosomes in Immunotherapy of Hepatocellular Carcinoma. Cancers (Basel) 2022;14:4036. [PMID: 36011030 DOI: 10.3390/cancers14164036] [Reference Citation Analysis]
4 Guan M, Wang M, Wang W, Li C, Yao L, Zhu H, Yang T. Exosomes as mediators of tumor immune escape and immunotherapy in hepatocellular carcinoma. Liver Research 2022. [DOI: 10.1016/j.livres.2022.08.001] [Reference Citation Analysis]
5 Zhang E, Phan P, Zhao Z. Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.08.020] [Reference Citation Analysis]
6 Zhao Y, Liu T, Zhou M. Immune-Cell-Derived Exosomes for Cancer Therapy. Mol Pharm 2022. [PMID: 35876318 DOI: 10.1021/acs.molpharmaceut.2c00407] [Reference Citation Analysis]
7 Ye J, Liu X. Macrophage-Derived Small Extracellular Vesicles in Multiple Diseases: Biogenesis, Function, and Therapeutic Applications. Front Cell Dev Biol 2022;10:913110. [DOI: 10.3389/fcell.2022.913110] [Reference Citation Analysis]
8 Jayasingam SD, Citartan M, Mat Zin AA, Rozhdestvensky TS, Tang T, Ch’ng ES. An Eleven-microRNA Signature Related to Tumor-Associated Macrophages Predicts Prognosis of Breast Cancer. IJMS 2022;23:6994. [DOI: 10.3390/ijms23136994] [Reference Citation Analysis]
9 Jorquera-cordero C, Lara P, Cruz LJ, Schomann T, van Hofslot A, de Carvalho TG, Guedes PMDM, Creemers L, Koning RI, Chan AB, de Araujo Junior RF. Extracellular Vesicles from M1-Polarized Macrophages Combined with Hyaluronic Acid and a β-Blocker Potentiate Doxorubicin’s Antitumor Activity by Downregulating Tumor-Associated Macrophages in Breast Cancer. Pharmaceutics 2022;14:1068. [DOI: 10.3390/pharmaceutics14051068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Yan Z, Yang K, Tang X, Bi Y, Ding Y, Deng M, Xia D, Zhao Y, Chen T, Wang F. Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis. Journal of Immunology Research 2022;2022:1-10. [DOI: 10.1155/2022/3851604] [Reference Citation Analysis]
11 Entezari M, Sadrkhanloo M, Rashidi M, Asnaf SE, Taheriazam A, Hashemi M, Ashrafizadeh M, Zarrabi A, Rabiee N, Hushmandi K, Mirzaei S, Sethi G. Non-coding RNAs and macrophage interaction in tumor progression. Crit Rev Oncol Hematol 2022;:103680. [PMID: 35405273 DOI: 10.1016/j.critrevonc.2022.103680] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
12 Devoto C, Guedes VA, Lai C, Leete JJ, Mithani S, Edwards K, Vorn R, Qu BX, Wilde EA, Walker WC, Diaz-Arrastia R, Werner JK, Kenney K, Gill JM. Remote blast-related mild traumatic brain injury is associated with differential expression of exosomal microRNAs identified in neurodegenerative and immunological processes. Brain Inj 2022;:1-10. [PMID: 35322723 DOI: 10.1080/02699052.2022.2042854] [Reference Citation Analysis]
13 Li S, Chen L. Exosomes in Pathogenesis, Diagnosis, and Treatment of Hepatocellular Carcinoma. Front Oncol 2022;12:793432. [PMID: 35155236 DOI: 10.3389/fonc.2022.793432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Wang Z, Zhao F, Zhao Y, Bai L, Hang R. Simultaneously enhanced osteogenesis and angiogenesis via macrophage-derived exosomes upon stimulation with titania nanotubes. Materials Science and Engineering: C 2022. [DOI: 10.1016/j.msec.2022.112708] [Reference Citation Analysis]
15 Wang C, Ma C, Gong L, Guo Y, Fu K, Zhang Y, Zhou H, Li Y. Macrophage Polarization and Its Role in Liver Disease. Front Immunol 2021;12:803037. [PMID: 34970275 DOI: 10.3389/fimmu.2021.803037] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
16 Lu W, Bai L, Chen Y. The Role of Macrophage-Derived Exosomes in Liver Diseases. Infectious Diseases & Immunity 2022;2:34-41. [DOI: 10.1097/id9.0000000000000034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Xu H, Xu B. BMSC-Derived Exosomes Ameliorate Osteoarthritis by Inhibiting Pyroptosis of Cartilage via Delivering miR-326 Targeting HDAC3 and STAT1//NF-κB p65 to Chondrocytes. Mediators Inflamm 2021;2021:9972805. [PMID: 34764819 DOI: 10.1155/2021/9972805] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
18 Shan X, Zhang C, Mai C, Hu X, Cheng N, Chen W, Peng D, Wang L, Ji Z, Xie Y. The Biogenesis, Biological Functions, and Applications of Macrophage-Derived Exosomes. Front Mol Biosci 2021;8:715461. [PMID: 34368234 DOI: 10.3389/fmolb.2021.715461] [Cited by in F6Publishing: 7] [Reference Citation Analysis]